Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Cornea and External Disease > These factors should be incorporated into corneal power calculations
  • Cornea and External Disease

These factors should be incorporated into corneal power calculations

Ophthalmology 360

Jascha Wendelstein, MD, of the Institute for Refractive and Ophthalmic Surgery, spoke with Ophthalmology 360 at the American Society of Cataract and Refractive Surgery Annual Meeting about the future of corneal power calculations.

Jascha Wendelstein, MD:

Hi, my name is Jascha Wendelstein. I’m currently working at 2 places. I’m working in Munich in Germany at the university clinic and I am working at the IROC Zurich in Switzerland, an institute founded by Professor Seiler who invented PRK and cross-linking. I am presenting today a study we did on the power of the epithelium and its role for either laser or IOL calculations. We based the study upon measurements by the MS-39, which is a hybrid placebo and OCT tomography device. We use maps to get 3 different corneal models to calculate corneal power, a model based on one refractive surface, only the anterior surface, a model based on 2 refractive surfaces, the anterior and the posterior surface. Then we had a third model which calculated the corneal power based on 3 refractive surfaces, which is the anterior power, the anterior stromal power, and the posterior power of the cornea.

We used the height map data from the tomography data we got and used floating best fit spheres to get the corneal radii to calculate it. We had 4 different cases. We had an exemplary normal eye. We had an exemplary eye after myopic laser vision correction and an exemplary eye after hyperopic laser vision correction and we had an eye with keratoconus. We then compared corneal power measured with 2 refractive surfaces, three refractive surfaces and compared that to 1 refractive surface. In the normal eye, the differences were not spectacular. It was a difference of about 0.05 diopters between the 2 refractive surfaces and the 3 refractive surfaces, so there’s not much to gain there. More interesting with the other eyes, the eye after myopic laser vision correction. We had a difference of around 0.4 diopters, so a 10-fold difference as compared to the normal eye and compared to the one refractive surface corneal power calculation, there was a bit more than a diopter of difference.

For the hyperopic eye, it was not as much. It was around 0.8 diopters difference between 1 surface and 3 surfaces. If we compared the 2 surface corneal, so only anterior and back to the three surfaces we were around 0.37, 0.38 again, that benchmark of around 0.4 diopters difference for the hyperopic laser vision correction. Now the most drastic differences we saw on the keratoconus eye where epithelium seems to play the highest role or the highest mistakes, if you want to put it like that.

We had differences of somewhere around 0.4 diopters for the more central regions and we had even higher differences of up to 0.9 diopters going outwards into the periphery, showing how much of a deviation there is between the 2 and the 3 refractive surface model. Very interestingly, comparing the 3 refractive surfaces to the one refractive surface, the difference was much, much more drastic. We had a difference of around 3.6 to 4 diopters between 3 surfaces and 1 surface. I think that goes to show that the future of corneal power calculations that can be used either for IOLs or for laser profiles is in the 3 refractive surface models, which can much more accurately display corneal power and can maybe try to correct some of those small mistakes that we still have in keratoconus eyes and eyes after laser vision correction. Thank you so much.

Share

Related Content

  • The Interventional Glaucoma Project

Improving Patient Experience and Practice Workflow With an Interventional Glaucoma Approach

  • The Interventional Glaucoma Project

Data-Driven Focus on Interventional Glaucoma Care

  • Conference Roundup

Cryopreserved amniotic membrane significantly improves ocular surface integrity in patients with severe keratoconjunctivitis sicca and neurotrophic keratopathy

  • Conference Roundup

CAM360 with a collagen shield provides rapid epithelial healing with better tolerability and safety than when used with bandage contact lenses

  • Conference Roundup

Enhanced monofocal IOLs provide better intermediate vision with no rings or dysphotopsia

  • Conference Roundup

Phase 1/2 CLARA study shows AURN001 improves BCVA compared with standard of care for corneal endothelial dysfunction

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon